Conference Reports

Hong Kong
19 October 2019 - 20 November 2019
22 November 2019 - 24 November 2019
Hong Kong
21 September 2019 - 21 September 2019
Barcelona
27 September 2019 - 01 October 2019
Amsterdam
13 June 2019 - 16 July 2019
Chicago, Illinois, US
31 May 2019 - 04 June 2019
Geneva, Switzerland
10 April 2019 - 13 April 2019
Atlanta, Georgia
29 March 2019 - 03 April 2019
16 March 2019 - 17 March 2019
San Francisco, California
14 February 2019 - 16 February 2019
19 January 2019 - 20 January 2019
San Francisco, California
17 January 2019 - 19 January 2019
San Antonio, Texas
04 December 2018 - 08 December 2018
San Diego, California, US
01 December 2018 - 04 December 2018
Singapore
23 November 2018 - 25 November 2018
Kuala Lumpur
22 November 2018 - 25 November 2018
Munich
19 October 2018 - 23 October 2018
Kuala Lumpur
01 October 2018 - 04 October 2018
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
Stockholm, Sweden
14 June 2018 - 17 June 2018
Chicago, Illinois
01 June 2018 - 05 June 2018
05 May 2018 - 06 May 2018
Chicago, Illinois, US
14 April 2018 - 18 April 2018
Barcelona, Spain
21 March 2018 - 23 March 2018
Geneva
11 April 2018 - 14 April 2018
Copenhagen
16 March 2018 - 19 March 2018
San Francisco, California
08 February 2018 - 10 February 2018
San Francisco, California, US
18 January 2018 - 20 January 2018
Hong Kong
20 January 2018 - 20 January 2018
Atlanta, Georgia, US
09 December 2017 - 12 December 2017
San Antonio, Texas, US
05 December 2017 - 09 December 2017
Singapore
17 November 2017 - 19 November 2017
San Diego, California, US
24 September 2017 - 27 September 2017
Madrid, Spain
08 September 2017 - 12 September 2017
Madrid
22 June 2017 - 25 June 2017
Chicago, Illinois, US
02 June 2017 - 06 June 2017
Geneva
05 May 2017 - 08 May 2017
Orlando, Florida
16 February 2017 - 18 February 2017
Amsterdam
27 January 2017 - 30 January 2017
Singapore
16 December 2016 - 19 December 2016
San Diego, California
03 December 2016 - 06 December 2016
San Antonio, Texas
06 December 2016 - 10 December 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, Yesterday
Transitioning from bortezomib- to ixazomib-based induction is feasible, tolerable and effective in the treatment of community patients with newly diagnosed multiple myeloma (NDMM), according to a study presented at the 61st Annual Meeting of the American Society of Hematology (ASH 2019).
Natalia Reoutova, 21 Nov 2019

Final analysis of the POEMS (Prevention of Early Menopause) study finds that breast cancer (BC) patients treated with the gonadotrophin-releasing hormone agonist (GnRHa) goserelin, in addition to chemotherapy, are more likely to avoid premature menopause and to become pregnant without negatively impacting disease-related outcomes.

Jairia Dela Cruz, 04 Dec 2019
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
Stephen Padilla, 05 Dec 2019
Circulating miR-155 may be potentially used as a diagnostic and therapeutic monitoring marker in breast cancer, suggests an Indonesian study presented at the 2019 Asia Congress of the European Society for Medical Oncology (ESMO Asia 2019).